TSPO versus P2X7 as target for neuroinflammation - an in vitro and in vivo study.
Objectives: Neuroinflammation is important in Amyotrophic Lateral Sclerosis (ALS). The P2X7 receptor (P2X7R) is a promising target for neuroinflammation. The objective was to compare 18F-DPA714, a second generation translocator protein tracer, with 11C-JNJ717, a novel P2X7R tracer, in vitro and in vivo in ALS. Methods: In vitro : Autoradiography with 18F-DPA714 and 11C-JNJ717 was performed on human ALS brain sections in comparison to immunofluorescence with Iba1 and GFAP. In vivo : Three early stage ALS patients (59.3±7.2y,3M) and 6 HV (48.2±16.5,2M) underwent dynamic PET-MR scanning with 18F-DPA714 and 11C-JNJ717. VT images were calculated using Logan plot and analysed on VOI basis. Results: Autoradiography showed no difference in 11C-JNJ717 binding, but increased 18F-DPA714 binding in motor cortex correlating with Iba1 expression (glial cells). Similar findings were observed in vivo with a 13% increased 18F-DPA714 binding in motor cortex. Conclusion: In symptomatic ALS patients, 18F-DPA714 showed increased signal while 11C-JNJ717 was not elevated.